Correlation Between PaxMedica, Common and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PaxMedica, Common Stock and Virax Biolabs Group, you can compare the effects of market volatilities on PaxMedica, Common and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Virax Biolabs.
Diversification Opportunities for PaxMedica, Common and Virax Biolabs
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between PaxMedica, and Virax is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Virax Biolabs go up and down completely randomly.
Pair Corralation between PaxMedica, Common and Virax Biolabs
If you would invest 86.00 in PaxMedica, Common Stock on August 28, 2024 and sell it today you would earn a total of 0.00 from holding PaxMedica, Common Stock or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 1.59% |
| Values | Daily Returns |
PaxMedica, Common Stock vs. Virax Biolabs Group
Performance |
| Timeline |
| PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Virax Biolabs Group |
PaxMedica, Common and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PaxMedica, Common and Virax Biolabs
The main advantage of trading using opposite PaxMedica, Common and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |